<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38383">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01756222</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00035836</org_study_id>
    <nct_id>NCT01756222</nct_id>
  </id_info>
  <brief_title>Bicuspid Aortic Valve Registry</brief_title>
  <acronym>BAV</acronym>
  <official_title>Bicuspid Aortic Valve and Ascending Aortic Aneurysm Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this registry is to gather information on patients with bicuspid aortic valve
      disease. The data collected in the registry will be used to assess patterns of aortic
      dilation, responses to medical therapy based on serial imaging and to assess for potential
      genetic markers of this disease
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">December 2040</completion_date>
  <primary_completion_date type="Anticipated">December 2040</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>30 Years</target_duration>
  <primary_outcome>
    <measure>Characterizing patients with bicuspid aortic valve disease</measure>
    <time_frame>30 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Identifying patients with bicuspid aortic valve disease, assessing the effect of medical intervention.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Bicuspid Aortic Valve Disease</condition>
  <arm_group>
    <arm_group_label>Bicuspid Aortic Valve Disease Patients</arm_group_label>
    <description>Patients with the diagnosis of BAV disease.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Primary clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient over the age of 18 who is able/willing to give informed consent with the
             diagnosis of bicuspid aortic valve disease, a family history of this disease or an
             ascending aortic aneurysm that is idiopathic can be included in the registry.

        Exclusion Criteria:

          -  Patients unable or unwilling to give informed consent.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna Booher, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nickole Calson, BSN</last_name>
    <phone>734-232-4780</phone>
    <email>ngarvey@med.umich.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Univeristy of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nickole Carlson, BSN</last_name>
      <phone>734-232-4780</phone>
      <email>ngarvey@med.umich.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 3, 2013</lastchanged_date>
  <firstreceived_date>December 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Anna Booher</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Bicuspid Aortic Valve Disease</keyword>
  <keyword>Bicuspid Aortic Valve</keyword>
  <keyword>BAV</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
